Anebulo Pharmaceuticals, Inc.ANEB

時価総額

$5420万

PER

	2021年 6月30日	2022年 6月30日	2023年 6月30日
Net loss	-30,252,554	-6,825,619	-11,732,338
Stock-based compensation	199,947	480,661	884,723
Prepaid expenses	-	-636,886	-608,212
Accounts payable	110,048	270,780	153,717
Accrued expenses	109,006	118	402,553
Net cash used in operating activities	-4,871,189	-5,437,174	-9,683,133
Proceeds from issuance of common stock to the public, net of underwriter discount	21	-	7
Offering costs	-	-	317,083
Proceeds from issuance of common stock upon exercise of options	-	-	52,400
Net cash provided by financing activities	22	-	6
Net decrease in cash	17	-5,437,174	-3,301,068